F > humans RiskAssessment

publications (hide)5
display
all
publications only
publications per page
5
10
20
50
100
sort by
added at
title
author
publication date
entry type
help for advanced sorting...
RSS
BibTeX
RDF
more...

1The problem of therapeutic efficacy indices. 1. Elements of the problem.
J. Boissel, M. Cucherat, F. Gueyffier, G. Chatellier, M. Buyse, W. Li, F. Boutitie, P. Nony, M. Haugh, and G. Mignot. Thérapie, 54 (2): 203-7 (1999)2966<m:linebreak></m:linebreak>Mesures de contrast.
2 years ago by @jepcastel
show all tags
Meta-AnalysisasTopic
RiskAssessment
Theoretical
Humans
Models
ClinicalTrialsasTopic
TreatmentOutcome
Meta-AnalysisasTopicRiskAssessmentTheoreticalHumansModelsClinicalTrialsasTopicTreatmentOutcome
copydeleteadd this publication to your clipboard
1Impact numbers: measures of risk factor impact on the whole population from case-control and cohort studies.
R. Heller, A. Dobson, J. Attia, and J. Page. Journal of epidemiology and community health, 56 (8): 606-10 (August 2002)2956<m:linebreak></m:linebreak>Mesures d'associació.
2 years ago by @jepcastel
show all tags
RiskAssessment
Disease
EpidemiologicMethods
RiskFactors
Case-ControlStudies
Humans
Incidence
RiskAssessment:methods
Disease:etiology
CohortStudies
TerminologyasTopic
RiskAssessmentDiseaseEpidemiologicMethodsRiskFactorsCase-ControlStudiesHumansIncidenceRiskAssessment:methodsDisease:etiologyCohortStudiesTerminologyasTopic
copydeleteadd this publication to your clipboard
1Analysis by categorizing or dichotomizing continuous variables is inadvisable: an example from the natural history of unruptured aneurysms.
O. Naggara, J. Raymond, F. Guilbert, D. Roy, A. Weill, and D. Altman. AJNR. American journal of neuroradiology, 32 (3): 437-40 (March 2011)6281<m:linebreak></m:linebreak>ClinicalTrials.gov/NCT00537134; GR: Canadian Institutes of Health Research/Canada; JID: 8003708; 2011/02/17 aheadofprint; ppublish;<m:linebreak></m:linebreak>Anàlisi de dades; Categorització.
2 years ago by @jepcastel
show all tags
IntracranialAneurysm:epidemiology
RiskAssessment
Ruptured:diagnosis
Prevalence
Aneurysm
Humans
IntracranialAneurysm
IntracranialAneurysm:diagnosis
DataInterpretation
ProportionalHazardsModels
ReproducibilityofResults
Ruptured:epidemiology
Ruptured
RiskFactors
Statistical
Bias(Epidemiology)
RiskAssessment:methods
SensitivityandSpecificity
IntracranialAneurysm:epidemiologyRiskAssessmentRuptured:diagnosisPrevalenceAneurysmHumansIntracranialAneurysmIntracranialAneurysm:diagnosisDataInterpretationProportionalHazardsModelsReproducibilityofResultsRuptured:epidemiologyRupturedRiskFactorsStatisticalBias(Epidemiology)RiskAssessment:methodsSensitivityandSpecificity
copydeleteadd this publication to your clipboard
1How to ascertain drug safety in the context of benefit. Controversies and concerns.
L. Simon, C. Strand, M. Boers, P. Brooks, P. Tugwell, C. Bombardier, J. Fries, D. Henry, L. Goldkind, G. Guyatt and 10 other author(s). The Journal of rheumatology, 36 (9): 2114-21 (September 2009)5429<m:linebreak></m:linebreak>JID: 7501984; 0 (Antirheumatic Agents); ppublish;.
2 years ago by @jepcastel
show all tags
RiskAssessment
RCT
Humans
RheumaticDiseases
Drug-RelatedSideEffectsandAdverseReactions
AntirheumaticAgents
RheumaticDiseases:drugtherapy
BiomedicalResearch
Postmarketing
Pharmacoepidemiology
AntirheumaticAgents:therapeuticuse
ProductSurveillance
Registries
AntirheumaticAgents:adverseeffects
RiskAssessmentRCTHumansRheumaticDiseasesDrug-RelatedSideEffectsandAdverseReactionsAntirheumaticAgentsRheumaticDiseases:drugtherapyBiomedicalResearchPostmarketingPharmacoepidemiologyAntirheumaticAgents:therapeuticuseProductSurveillanceRegistriesAntirheumaticAgents:adverseeffects
copydeleteadd this publication to your clipboard
1Spatial and temporal modelling for parasite transmission studies and risk assessment.
F. Danson, R. Armitage, and C. Marston. Parasite (Paris, France), 15 (3): 463--468 (2008)abstract_only, 2review.
15 years ago by @uvesco
show all tags
RiskAssessment
Animals
Humans
SatelliteCommunications
Topography
Models
vectorbornedisease
Biological
model
Medical
GeographicInformationSystems
ParasiticDiseases
RiskAssessmentAnimalsHumansSatelliteCommunicationsTopographyModelsvectorbornediseaseBiologicalmodelMedicalGeographicInformationSystemsParasiticDiseases
copydeleteadd this publication to your clipboard

⟨⟨
⟨
1
⟩
⟩⟩

BibSonomy

publications (hide)5
display
all
publications only
publications per page
5
10
20
50
100
sort by
added at
title
author
publication date
entry type
help for advanced sorting...
RSS
BibTeX
RDF
more...

1The problem of therapeutic efficacy indices. 1. Elements of the problem.

1Impact numbers: measures of risk factor impact on the whole population from case-control and cohort studies.

1Analysis by categorizing or dichotomizing continuous variables is inadvisable: an example from the natural history of unruptured aneurysms.

1How to ascertain drug safety in the context of benefit. Controversies and concerns.

1Spatial and temporal modelling for parasite transmission studies and risk assessment.

related tags

tags

BibSonomy

publications (hide)5 displayallpublications onlypublications per page5102050100 sort byadded attitleauthorpublication dateentry typehelp for advanced sorting... RSSBibTeXRDFmore...

1The problem of therapeutic efficacy indices. 1. Elements of the problem.

1Impact numbers: measures of risk factor impact on the whole population from case-control and cohort studies.

1Analysis by categorizing or dichotomizing continuous variables is inadvisable: an example from the natural history of unruptured aneurysms.

1How to ascertain drug safety in the context of benefit. Controversies and concerns.

1Spatial and temporal modelling for parasite transmission studies and risk assessment.

related tags

tags

publications (hide)5
display
all
publications only
publications per page
5
10
20
50
100
sort by
added at
title
author
publication date
entry type
help for advanced sorting...
RSS
BibTeX
RDF
more...